Prognostic Significance of Ultrasound Myocardial Tissue Characterization in Patients With Cardiac Amyloidosis
暂无分享,去创建一个
[1] R. Falk,et al. Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. , 1998, Blood.
[2] Brent K. Hoffmeister,et al. Detection of Unique Transmural Architecture of Human Idiopathic Cardiomyopathy by Ultrasonic Tissue Characterization , 1992, Circulation.
[3] A. Weyman,et al. Preload dependence of Doppler-derived indexes of left ventricular diastolic function in humans. , 1987, Journal of the American College of Cardiology.
[4] L Landini,et al. Increased echodensity of myocardial wall in the diabetic heart: an ultrasound tissue characterization study. , 1995, Journal of the American College of Cardiology.
[5] L. Landini,et al. Quantitative assessment of ultrasonic myocardial reflectivity in hypertrophic cardiomyopathy. , 1991, Journal of the American College of Cardiology.
[6] J. Seward,et al. M‐mode and Two‐dimensional Echocardiographic Features in Cardiac Amyloidosis , 1981, Circulation.
[7] C. Angermann,et al. Recognition of acute cardiac allograft rejection from serial integrated backscatter analyses in human orthotopic heart transplant recipients. Comparison with conventional echocardiography. , 1997, Circulation.
[8] E. Arbustini,et al. Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis , 2002, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.
[9] J. Seward,et al. Prognostic Significance of Doppler Measures of Diastolic Function in Cardiac Amyloidosis: A Doppler Echocardiography Study , 1991, Circulation.
[10] J. G. Miller,et al. Abnormal myocardial acoustic properties in diabetic patients and their correlation with the severity of disease. , 1992, Journal of the American College of Cardiology.
[11] J. Seward,et al. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. , 1985, Journal of the American College of Cardiology.
[12] David R. Cox,et al. Regression models and life tables (with discussion , 1972 .
[13] I Schnittger,et al. Ultrasonic tissue characterization with a real time integrated backscatter imaging system in normal and aging human hearts. , 1989, Journal of the American College of Cardiology.
[14] Prognostic Significance of Doppler Measures of Diastolic Function in Cardiac Amyloidosis , 1991 .
[15] R. Bonow,et al. Alterations in ultrasonic backscatter during exercise-induced myocardial ischemia in humans. , 1995, Circulation.
[16] J G Miller,et al. Quantitative assessment of myocardial ultrasound tissue characterization through receiver operating characteristic analysis of Bayesian classifiers. , 1995, Journal of the American College of Cardiology.
[17] J. Seward,et al. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. , 1989, Journal of the American College of Cardiology.
[18] P Colonna,et al. Effects of acute myocardial ischemia on intramyocardial contraction heterogeneity: A study performed with ultrasound integrated backscatter during transesophageal atrial pacing. , 1999, Circulation.
[19] W. O’Brien,et al. Relation of ultrasonic backscatter and acoustic propagation properties to myofibrillar length and myocardial thickness. , 1995, Circulation.
[20] R. Popp,et al. Ultrasonic tissue characterization of human hypertrophied hearts in vivo with cardiac cycle-dependent variation in integrated backscatter. , 1989, Circulation.
[21] L S Wann,et al. Intramyocardial variability in integrated backscatter: effects of coronary occlusion and reperfusion. , 1987, Circulation.
[22] A J Tajik,et al. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. , 1996, Journal of the American College of Cardiology.
[23] J. Seward,et al. Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. , 1990, Journal of the American College of Cardiology.
[24] R. Falk,et al. An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis , 2001, Bone Marrow Transplantation.
[25] M. Hori,et al. Analysis of transmural trend of myocardial integrated ultrasound backscatter for differentiation of hypertrophic cardiomyopathy and ventricular hypertrophy due to hypertension. , 1994, Journal of the American College of Cardiology.
[26] J. G. Miller,et al. A relationship between ultrasonic integrated backscatter and myocardial contractile function. , 1985, The Journal of clinical investigation.
[27] J. G. Miller,et al. Three-dimensional characterization of human ventricular myofiber architecture by ultrasonic backscatter. , 1991, The Journal of clinical investigation.
[28] J. G. Miller,et al. Ultrasonic characterization of myocardium. , 1985, Progress in cardiovascular diseases.
[29] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[30] I Schnittger,et al. Serial measurement of integrated ultrasonic backscatter in human cardiac allografts for the recognition of acute rejection. , 1990, Circulation.
[31] L. Wann,et al. Influence of heart rate, preload, afterload, and inotropic state on myocardial ultrasonic backscatter. , 1988, Circulation.
[32] R. Falk,et al. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. , 1987, The American journal of cardiology.
[33] J. G. Miller,et al. Quantitative ultrasonic tissue characterization with real-time integrated backscatter imaging in normal human subjects and in patients with dilated cardiomyopathy. , 1987, Circulation.